Overview


According to FutureWise analysis the market for Narcolepsy in 2023 is US$ 3.03 billion, and is expected to reach US$ 6.46 billion by 2031 at a CAGR of 9.92%.

A long-term neurological condition called narcolepsy interferes with the brain's capacity to regulate sleep-wake cycles. Narcoleptics may feel rested when they first wake up but then experience extreme sleepiness for the majority of the day. Many individuals who have narcolepsy also have unsteady, interrupted sleep, which can include frequent nighttime awakenings. Daily tasks can be significantly impacted by narcolepsy. Individuals might unintentionally fall asleep while in the middle of an activity, like talking, eating, or driving. Other signs may include hallucinations or intense dream-like pictures, sudden muscle weakness that renders a person limp or immobile while awake (cataplexy), and total paralysis shortly before or right after waking up (sleep paralysis).

The market is primarily driven by the aging population's need for healthcare, the rise in narcoleptic disorders, changing lifestyles, and the link between stress and narcolepsy issues. The narcolepsy market is anticipated to be driven by increased research efforts, an increase in healthcare spending, and the presence of superior medical infrastructure. To increase knowledge of sleep disorders and the availability of therapies linked to narcolepsy, several local, national, and international agencies and organizations have taken initiative measures. This insight represents opportunities for market expansion over the predicted time frame.

FutureWise Market Research has published a report that provides an insightful analysis of narcolepsy market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, the narcolepsy market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Addrenex Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd
  • Shire Plc
  • GrayMark Healtcare Inc
  • Bioproject
  • Arena Pharmaceuticals Inc
  • Jazz Pharmaceuticals Plc
  • Novartis AG
  • Ligand Pharmaceuticals Inc

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Narcolepsy Market:

  • In March 2022- Axsome Therapeutics Inc. and Jazz Pharmaceuticals entered into a legally binding agreement to buy Sunosi (solriamfetol), which is used to treat adult patients with excessive daytime sleepiness (EDS) brought on by narcolepsy or obstructive sleep apnea (OSA).

The primary factors affecting the growth of the narcolepsy market are an increase in the prevalence of narcolepsy and an increase in the number of obese individuals. Narcolepsy medications can be used to treat sleep apnea. Expanding disposable income and more knowledge of the benefits of narcolepsy medications are also projected to promote global market expansion. Since it has fewer negative effects than other stimulants, utilizing modafinil to treat patients also helps the drug's market expansion. Therefore, effective treatment can aid in preventing such ailments, propelling the narcolepsy market throughout the forecast period. Moreover, numerous local, regional, and international institutes, organizations, and councils work to spread awareness about narcolepsy-related problems and viable solutions. For instance, the non-profit group "Wake Up Narcolepsy" promotes public well-being by driving the hunt for a cure for disorders. To increase awareness and reduce social stigma among those who also experience the condition, Project Sleep, a non-profit organization with headquarters in the US, launched a program called "Rising Voices of Narcolepsy" that train those who have the condition to share their stories with their communities both verbally and in writing. In addition, the rapid acceptance of a novel therapy for the treatment of narcolepsy is predicted to boost the market. However, market growth is anticipated to be constrained by the side effects of narcolepsy drugs and the possibility of delayed diagnosis and treatment. The dearth of knowledge among patients and medical professionals in developed and emerging nations further restricts the market growth of narcolepsy. The government's stringent regulations governing the agreement for narcolepsy drugs are another factor anticipated to constrain market growth.

By Type

  • Type 1 Narcolepsy
  • Type 2 Narcolepsy  

By Medication

  • Modafinil
  • Amphetamine-like Stimulants
  • Antidepressants
  • Sodium Oxybate

By Diagnosis

  • Polysomnogram(PSG)
  • Multiple Sleep Latency Test (MSLT)
  • Epworth Sleepiness Scale (ESS)
  • Actigraph
  • Others

By End Use

  • Hospitals
  • Diagnostic Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. The market is anticipated to be driven by high healthcare spending and the rising prevalence of narcoleptic illnesses. The other elements projected to support revenue growth include favorable reimbursement regulations for treatments, a solid clinical pipeline, and rising stress levels. Narcolepsy affects somewhere between 135,000 and 200,000 people in the United States, according to a data sheet updated in November 2021 by the National Institute of Neurological Disorders and Stroke. However, the number may be substantially higher because this condition is commonly misdiagnosed. The high frequency of narcolepsy in industrialized nations like the United States will increase the use of narcolepsy treatments, fueling market expansion in this region.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Narcolepsy Market By Type, By Medication, By Diagnosis, By End Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Narcolepsy Market Variables, Trends and Scope
    •        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Narcolepsy Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Narcolepsy Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Narcolepsy Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Type 1 Narcolepsy
        2. Type 2 Narcolepsy

  • 8.   Narcolepsy Market, By Medication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Modafinil
        2. Amphetamine-like Stimulants
        3. Antidepressants
        4. Sodium Oxybate

  • 9.   Narcolepsy Market, By Diagnosis Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Polysomnogram(PSG)
        2. Multiple Sleep Latency Test (MSLT)
        3. Epworth Sleepiness Scale (ESS)
        4. Actigraph
        5. Others

  • 10.   Narcolepsy Market, By End Use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Centers
        3. Others

  • 11.   North America Narcolepsy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Narcolepsy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Narcolepsy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Narcolepsy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Narcolepsy Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Addrenex Pharmaceuticals
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Teva Pharmaceutical Industries Ltd
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Shire Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. GrayMark Healtcare Inc
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bioproject
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Arena Pharmaceuticals Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Jazz Pharmaceuticals Plc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Novartis AG
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Ligand Pharmaceuticals Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients